Skip to main content
SpringerLink
Log in

The pathogenesis of cancer metastasis: relevance to therapy

  • Chapter
Principles of Cancer Biotherapy

Metastasis, the spread of malignant tumor cells from a primary neoplasm to distant parts of the body where they multiply to form new growths, is a major cause of death from cancer. The treatment of cancer poses a major problem to clinical oncologists, because by the time many cancers are diagnosed, metastasis may already have occurred, and the presence of multiple metastases makes complete eradication by surgery, radiation, drugs, or biotherapy nearly impossible. Metastases can be located in different organs and in different locations within the same organ. These aspects significantly influence the response of tumor cells to therapy and the efficiency of anticancer drugs, which must be delivered to tumor lesions to destroy cells without leading to undesirable side effects. Similarly, immune effector cells of current biotherapeu-tic regimens may not reach or localize in metastases with different organs.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 259.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 329.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Arteaga CL. The epidermal growth factor receptor: from mutant oncogene in nonhuman cancers to therapeutic target in human neoplasia. J Clin Oncol 2001; 19: 32s–40s.

    CAS  PubMed  Google Scholar 

  2. Atlas I, Mendelsohn J, Baselga J, Fair WR, Masui H, Kumar R. Growth regulation of human renal carcinoma cells: role of transforming growth factor α. Cancer Res 1992; 52: 3335–9.

    CAS  PubMed  Google Scholar 

  3. Auerbach W, Auerbach R. Angiogenesis inhibition: a review. Pharmacol Ther 1994; 63: 265–311.

    Article  CAS  PubMed  Google Scholar 

  4. Augustin HG, Kmeta J, Alves F, et al. Quantitating angiogenesis and assessing the causal relationship between angiogenesis and tumorigenesis: problems and progress. Ann Hematol 2002; 81(Suppl 2): 68–72.

    Google Scholar 

  5. Baker CH, Fidler IJ. Tumor microenvironment and angiogenesis. In: Davis DW, Herbst RS, Abbruzzese JL, eds. Antiangiogenic cancer therapy. Boca Raton, FL: CRC Press, 2008: 131–47.

    Google Scholar 

  6. Baker CH, Kedar D, McCarty MF, Tsan R, Weber KL, Bucana CD, Fidler IJ. Blockade of epidermal growth factor receptor signaling on tumor cells and tumor-associated endothelial cells for therapy of human carcinomas. Am J Pathol 2002; 161: 929–38.

    CAS  PubMed  Google Scholar 

  7. Baker CH, Solorzano CC, Fidler IJ. Blockade of the vascular endothelial growth factor receptor and epidermal growth factor receptor signaling for therapy of metastatic human pancreatic cancer. Cancer Res 2002; 62: 1996–2003.

    CAS  PubMed  Google Scholar 

  8. Bancroft CC, Chen Z, Yeh J, Sunwoo JB, Yeh NT, Jackson S, Jackson C, Van Waes C. Effects of pharmacologic antagonists of epidermal growth factor receptor, PI3K and MEK signal kinases on NF-kappaB and AP-1 activation and IL-8 and VEGF expression in human head and neck squamous cell carcinoma lines. Int J Cancer 2002; 99: 538–48.

    Article  CAS  PubMed  Google Scholar 

  9. Barrier A, Boelle P Y, Roser F, et al. Stage II colon cancer prognosis prediction by tumor gene expression profiling. J Clin Oncol 2006; 24: 4685–91.

    Article  CAS  PubMed  Google Scholar 

  10. Beer DG, Kardia SL, Huang CC, et al. Gene expression profiles predict survival of patients with lung adenocarcinoma. Nat Med 2002; 8: 816–24.

    CAS  PubMed  Google Scholar 

  11. Beer T, Raghavan D. Chemotherapy for hormone refractory prostate cancer: beauty is in the eye of the beholder. Prostate 2000; 45: 183–93.

    Article  Google Scholar 

  12. Benjamin LE, Hemo I, Keshet E. A plasticity window for blood vessel remodeling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF. Development 1998; 125: 1591–8.

    CAS  PubMed  Google Scholar 

  13. Bergers G, Benjamin LE. Tumorigenesis and the angiogenic switch. Nat Rev Cancer 2003; 3: 401–10.

    Article  CAS  PubMed  Google Scholar 

  14. Bergers G, Song S, Meyer-Morse N, Bergsland E, Hanahan D. Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors. J Clin Invest 2003; 111: 1287–95.

    CAS  PubMed  Google Scholar 

  15. Bergsten E, Uutela M, Li X, Pietras K, Ostman A, Heldikn CH, Alitalo K, Eriksson U. PDGF-D is a specific, protease-activated ligand for the PDGF beta-receptor. Nat Cell Biol 2001; 3: 512–6.

    Article  CAS  PubMed  Google Scholar 

  16. Black MM, Freeman C, Mork T, Harvei S, Cutler SJ. Prognostic significance of microscopic structure of gastric carcinomas and their regional lymph nodes. Cancer 1971; 27: 703–10.

    Article  CAS  PubMed  Google Scholar 

  17. Bogaerts J, Cardoso F, Buyse M, et al. Gene signature evaluation as a prognostic tool: challenges in the design of the MINDACT trial (Review). Nat Clin Pract Oncol 2006; 3: 540–51.

    Article  CAS  PubMed  Google Scholar 

  18. Bradley G, Juranka PE, Ling V. Mechanism of multidrug resistance. Biochim Biophys Acta 1988; 984: 87–128.

    Google Scholar 

  19. Brocker EB, Reckenfeld C, Hamm H, Ruiter DJ, Sorg C. Macrophages in melanocytic naevi. Arch Dermatol Res 1992; 284: 127–31.

    Article  CAS  PubMed  Google Scholar 

  20. Bruns CJ, Harbison MT, David DW, et al. Epidermal growth factor receptor blockade with C225 plus gemcitabine results in regression of human pancreatic carcinoma growing orthotopically in nude mice by antiangiogenic mechanisms. Clin Cancer Res 2000; 6: 1936–48.

    CAS  PubMed  Google Scholar 

  21. Bruns CJ, Solorzano CC, Harbison MT, et al. Blockade of epidermal growth factor receptor signaling by a novel tyrosine kinase inhibitor leads to apoptosis of endothelial cells and therapy of human pancreatic carcinoma. Cancer Res 2000; 60: 2926–35.

    CAS  PubMed  Google Scholar 

  22. Buchdunger E, CioffiCL, Law N, et al. Abl protein-tyrosine kinase inhibitor STI571 inhibits in vitro signal transduction mediated by c-kit and platelet-derived growth factor receptors. J Pharmacol Exp Ther 2000; 295: 139–45.

    CAS  PubMed  Google Scholar 

  23. Busby JE, Kim SJ, Yazici S, et al. Therapy of multidrug resistant human prostate tumors in the prostate of nude mice by simultaneous targeting of the epidermal growth factor receptor and vascular endothelial growth factor receptor on tumor-associated endothelial cells. Prostate 2006; 66: 1788–98.

    Article  CAS  PubMed  Google Scholar 

  24. Busse D, Yakes FM, Lenferink AE, Arteaga CL. Tyrosine kinase inhibitors: rationale, mechanisms of action, and implications for drug resistance. Semin Oncol 2001; 28: 47–55.

    Article  CAS  PubMed  Google Scholar 

  25. Byers RM. Modified neck dissection: a study of 967 cases from 1970 to 1980. Am J Surg 1985; 150: 414–21.

    Article  CAS  PubMed  Google Scholar 

  26. Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature 2000; 407: 249–57.

    Article  CAS  PubMed  Google Scholar 

  27. Carr I. Lymphatic metastasis. Cancer Metastasis Rev 1983; 22: 307–19.

    Google Scholar 

  28. Chang JC, Wooten EC, Tsimelzon A, et al. Gene expression profiling for the prediction of therapeutic response to docetaxel in patients with breast cancer. Lancet 2003; 362: 362–9.

    Article  CAS  PubMed  Google Scholar 

  29. Chen CN, Lin JJ, Chen JJ, et al. Gene expression profile predicts patient survival of gastric cancer after surgical resection. J Clin Oncol 2005; 23: 7286–95.

    Article  CAS  PubMed  Google Scholar 

  30. Ciardiello F, Bianco R, Caputo R, et al. Antitumor activity of ZD6474, a vascular endothelial growth factor receptor tyrosine kinase inhibitor, in human cancer cells with acquired resistance to anti-epidermal growth factor receptor therapy. Clin Cancer Res 2004; 10: 784–93.

    Article  CAS  PubMed  Google Scholar 

  31. Cifone MA, Fidler IJ. Increasing metastatic potential is associated with increasing genetic instability of clones isolated from murine neoplasms. Proc Natl Acad Sci USA 1982; 78: 6949–52.

    Article  Google Scholar 

  32. Clark WH, Elder DE, Guerry D, Epstein ME, Green MH, VanHorn M. A study of tumor progression: the precursor lesions of superficial spreading and nodular melanoma. Hum Pathol 1984; 15: 1147–62.

    Article  PubMed  Google Scholar 

  33. Clark WH, Elder DE, VanHorn M. The biologic forms of malignant melanoma. Hum Pathol 1986; 17: 443–69.

    Article  PubMed  Google Scholar 

  34. Cole SP, Bhardwaj G, Gerlach JH, et al. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science 1992; 258: 1650–4.

    Article  CAS  PubMed  Google Scholar 

  35. Colombel M, Symmans F, Gil S, et al. Detection of the apoptosis-suppressing oncoprotein Bcl-2 in hormone-refractory human prostate cancers. Am J Pathol 1993; 143: 390–400.

    CAS  PubMed  Google Scholar 

  36. Cox CE, Pendas S, Cox JM, et al. Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer. Ann Surg 1998; 227: 645–53.

    Article  CAS  PubMed  Google Scholar 

  37. Debnath J, Brugge JS. Modeling glandular epithelial cancers in three-dimensional cultures. Nat Rev Cancer 2005; 5(9): 675–88.

    Article  CAS  PubMed  Google Scholar 

  38. Ding A, Hwang S, Schwab R. Effect of aging on murine macrophages: diminished response to IFN-ã for enhanced oxidative metabolism. J Immunol 1994; 153: 2146–52.

    CAS  PubMed  Google Scholar 

  39. Dinjens WN, van der Weiden MM, Schroeder FH, Bosman FT, Trapman J. Frequency and characterization of p53 mutations in primary and metastatic human prostate cancer. Int J Cancer 1994; 56: 630–3.

    Article  CAS  PubMed  Google Scholar 

  40. DiPietro L, Polverini PJ. Angiogenic macrophages produce the angiogenic factor thrombospondin 1. Am J Pathol 1993; 143: 678–84.

    Google Scholar 

  41. Donelli MG, Russo R, Garattini S. Selective chemotherapy in relation to the site of tumor transplantation. Int J Cancer 1967; 2: 421–4.

    Article  CAS  PubMed  Google Scholar 

  42. Dong Z, Kumar R, Yang X, Fidler IJ. Macrophage-derived metal-loelastase is responsible for the generation of angiostatin in Lewis lung carcinoma. Cell 1997; 88: 801–10.

    Article  CAS  PubMed  Google Scholar 

  43. Dong Z, Radinsky R, Fan D, et al. Organ-specific modulation of steady-state mdr-1 gene expression and drug resistance in murine colon cancer cells. J Natl Cancer Inst 1994; 86: 913–20.

    Article  CAS  PubMed  Google Scholar 

  44. Druker BJ, Tamura S, Buchdunger E, et al. Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells. Nat Med 1996; 2: 561–6.

    Article  CAS  PubMed  Google Scholar 

  45. Dvorak HF. Tumors: wounds that do not heal: similarities between tumor stroma generation and wound healing. N Engl J Med 1986; 315: 1650–9.

    Article  CAS  PubMed  Google Scholar 

  46. Dvorak HF, Brown LF, Detmar M, Dvorak AM. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 1995; 146: 1029–39.

    CAS  PubMed  Google Scholar 

  47. Dvorak HF, Seneger DR, Dvorak AM. Fibrin as a component of the tumor stroma: origins and biological significance. Cancer Metastasis Rev 1983; 2: 41–75.

    Article  CAS  PubMed  Google Scholar 

  48. Eberhard A, Kahlert S, Goede V, Hemmerlein B, Plate KH, Augustin HG. Heterogeneity of angiogenesis and blood vessel maturation in human tumors: implications for antiangiogenic tumor therapies. Cancer Res 2000; 60: 1388–93.

    CAS  PubMed  Google Scholar 

  49. Erber R, Thurnher A, Katsen AD, et al. Combined inhibition of VEGF and PDGF signaling enforces tumor vessel regression by interfering with pericyte-mediated endothelial cell survival mechanisms. FASEB J 2004; 18: 338–40.

    CAS  PubMed  Google Scholar 

  50. Ewing J. Neoplastic diseases. 6th edt. Philadelphia, PA: WB Saunders, 1928.

    Google Scholar 

  51. Fabra A, Nakajima M, Bucana CD, Fidler IJ. Modulation of the invasive phenotype of human colon carcinoma cells by fibroblasts from orthotopic or ectopic organs of nude mice. Differentiation 1992; 52: 101–10.

    Article  CAS  PubMed  Google Scholar 

  52. Ferrara N, Alitalo K. Clinical applications of angiogenic growth factors and their inhibitors. Nat Med 1999; 5: 1359–64.

    Article  CAS  PubMed  Google Scholar 

  53. Ferrara N, Davis-Smyth T. The biology of vascular endothelial growth factor. Endocrinol Rev 1997; 18: 4–25.

    Article  CAS  Google Scholar 

  54. Ferrara N, Gerber HP, LeCouter J. The biology of VEGF and its receptors. Nat Med 2003; 9: 669–76.

    Article  CAS  PubMed  Google Scholar 

  55. Fidler IJ. Angiogenic heterogeneity: regulation of neoplastic angiogenesis by the organ microenvironment (Editorial). J Natl Cancer Inst 2001; 93: 1040–1.

    Article  CAS  PubMed  Google Scholar 

  56. Fidler IJ. Biology of cancer metastasis. In: Abeloff MD, Armitage JO, Niederhuber JE, Kastan MB, McKenna WG, eds. Clinical oncology, 3rd edt. Philadelphia, PA: Elsevier Sciencem 2004; 59–79.

    Google Scholar 

  57. Fidler IJ. Critical determinants of metastasis. Semin Cancer Biol 2002; 12: 89–96.

    Article  PubMed  Google Scholar 

  58. Fidler IJ. Critical factors in the biology of human cancer metastasis: twenty-eighth G H A Clowes Memorial Award Lecture. Cancer Res 1990; 50: 6130–8.

    CAS  PubMed  Google Scholar 

  59. Fidler IJ. Lymphocytes are not only immunocytes (Guest Editorial). Biomedicine 1980; 32: 1–3.

    CAS  PubMed  Google Scholar 

  60. Fidler IJ. Metastasis: quantitative analysis of distribution and fate of tumor emboli labeled with 125I-5-iodo-2′-deoxyuridine. J Natl Cancer Inst 1970; 45: 773–82.

    CAS  PubMed  Google Scholar 

  61. Fidler IJ. Orthotopic implantation of human colon carcinomas into nude mice provides a valuable model for the biology and therapy of cancer metastasis. Cancer Metastasis Rev 1991; 10: 229–43.

    Article  CAS  PubMed  Google Scholar 

  62. Fidler IJ. The organ microenvironment and cancer metastasis. Differentiation 2002; 70: 498–505.

    Article  PubMed  Google Scholar 

  63. Fidler IJ. The pathogenesis of cancer metastasis: the ‘seed and soil’ hypothesis revisited (Timeline). Nat Rev Cancer 2003; 3: 453–8.

    Article  CAS  PubMed  Google Scholar 

  64. Fidler IJ. Rationale and methods for the use of nude mice to study the biology and therapy of human cancer metastasis. Cancer Metastasis Rev 1986; 5: 29–49.

    Article  CAS  PubMed  Google Scholar 

  65. Fidler IJ. “Seed and soil” revisited: contribution of the organ microenvironment to cancer metastasis. In: Brodt P, ed. Surgical oncology clinics of NA: cancer metastasis: biological and clinical aspects. Philadelphia, PA: WB Saunders, 2001: 257–69.

    Google Scholar 

  66. Fidler IJ. Selection of successive tumor lines for metastasis. Nature (New Biol) 1973; 242: 148–9.

    CAS  Google Scholar 

  67. Fidler IJ, Bucana C. Mechanism of tumor cell resistance to lysis by syngeneic lymphocytes. Cancer Res 1977; 37: 3945–56.

    CAS  PubMed  Google Scholar 

  68. Fidler IJ, Gersten DM, Kripke ML. Influence of the immune status on the metastasis of three murine fibrosarcomas of different immu-nogenicities. Cancer Res 1979; 39: 3816–21.

    CAS  PubMed  Google Scholar 

  69. Fidler IJ, Gruys E, Cifone MA, Barnes Z, Bucana C. Demonstration of multiple phenotypic diversity in a murine melanoma of recent origin. J Natl Cancer Inst 1981; 67: 947–56.

    CAS  PubMed  Google Scholar 

  70. Fidler IJ, Kim SJ, Langley RR. The role of the organ microenvironment in the biology and therapy of cancer metastasis. J Cell Biochem 2007; 101: 927–36.

    Article  CAS  PubMed  Google Scholar 

  71. Fidler IJ, Kripke ML. Metastasis results from pre-existing variant cells within a malignant tumor. Science 1977; 197: 893–5.

    Article  CAS  PubMed  Google Scholar 

  72. Fidler IJ, Langley RR, Kerbel RS, Ellis LM. Biology of cancer: angiogenesis. In: DeVita VT Jr, Hellman S, Rosenberg SA, eds. Cancer: principles and practice of oncology, 7th edt. Philadelphia, PA: Lippincott & Wilkins, 2005; 129–37.

    Google Scholar 

  73. Fidler IJ, Nicolson GL. Organ selectivity for implantation survival and growth of B16 melanoma variant tumor lines. J Natl Cancer Inst 1976; 57: 1199–202.

    CAS  PubMed  Google Scholar 

  74. Fidler IJ, Poste G. The cellular heterogeneity of malignant neoplasms: implications for adjuvant chemotherapy. Semin Oncol 1985; 12: 207–21.

    CAS  PubMed  Google Scholar 

  75. Fidler IJ, Talmadge JE. Evidence that intravenously derived murine pulmonary metastases can originate from the expansion of a single tumor cell. Cancer Res 1986; 46: 5167–71.

    CAS  PubMed  Google Scholar 

  76. Fidler IJ, Wilmanns C, Staroselsky A, Radinsky R, Dong Z, Fan D. Modulation of tumor cell response to chemotherapy by the organ environment. Cancer Metastasis Rev 1994; 13: 209–22.

    Article  CAS  PubMed  Google Scholar 

  77. Fidler IJ, Yano S, Zhang R-D, Fujimaki T, Bucana CD. The seed and soil hypothesis: vascularization and brain metastases (Personal View). Lancet Oncol 2002; 3: 53–7.

    Article  CAS  PubMed  Google Scholar 

  78. Folkman J. How is blood vessel growth regulated in normal and neoplastic tissue? G H A Clowes Memorial Award Lecture. Cancer Res 1986; 46: 467–73.

    CAS  PubMed  Google Scholar 

  79. Folkman J. The role of angiogenesis in tumor growth. Semin Cancer Biol 1992; 3: 65–71.

    CAS  PubMed  Google Scholar 

  80. Folkman J, Klagsburn M. Angiogenic factors. Science 1987; 235: 444–7.

    Article  Google Scholar 

  81. Foulds L. The experimental study of tumor progression: a review. Cancer Res 1954; 14: 327–39.

    CAS  PubMed  Google Scholar 

  82. Fracasso PM, Westervelt P, Fears CL, et al. Phase I study of pacli-taxel in combination with a multidrug resistance modulator, PSC 833 (Valspodar), in refractory malignancies. J Clin Oncol 2000; 18: 1124–34.

    CAS  PubMed  Google Scholar 

  83. Freeman MR, Schneck FX, Gagnon ML, et al. Peripheral blood T-lymphocytes and lymphocytes infiltrating human cancers express vascular endothelial growth factor: a potential role for T cells in angiogenesis. Cancer Res 1995; 55: 4140–5.

    CAS  PubMed  Google Scholar 

  84. Furuhashi M, Sjoblom T, Abramsson A, et al. Platelet-derived growth factor production by B16 melanoma cells leads to increased pericyte abundance in tumors and an associated increase in tumor growth rate. Cancer Res 2004; 64: 2725–33.

    Article  CAS  PubMed  Google Scholar 

  85. Gerber HP, Dixit V, Ferrara N. Vascular endothelial growth factor induces expression of the antiapoptotic proteins Bcl-2 and A1 in vascular endothelial cells. J Biol Chem 1998; 273: 13313–6.

    Article  CAS  PubMed  Google Scholar 

  86. Gerber HP, McMurtrey A, Kowalski J, et al. Vascular endothelial growth factor regulates endothelial cell survival through the phos-phatidylinositol 3′-kinase/Akt signal transduction pathway: requirement for Flk-1/KDR activation. J Biol Chem 1998; 273: 30336–43.

    Article  CAS  PubMed  Google Scholar 

  87. Gerhardt H, Betsholtz C. Endothelial-pericyte interactions in angiogenesis. Cell Tissue Res 2003; 314: 15–23.

    Article  PubMed  Google Scholar 

  88. Gerritsen ME. Functional heterogeneity of vascular endothelial cells. Biochem Pharmacol 1987; 36: 2701–11.

    Article  CAS  PubMed  Google Scholar 

  89. Ghadimi BM, Grade M, Difilippantonio MJ, et al. Effectiveness of gene expression profiling for response prediction of rectal adeno-carcinomas to preoperative chemoradiotherapy. J Clin Oncol 2005; 23: 1826–38.

    Article  CAS  PubMed  Google Scholar 

  90. Gisselsson D, Pettersson L, Hoglund M, et al. Chromosomal breakage-fusion-bridge events cause genetic intratumor heterogeneity. Proc Natl Acad Sci USA 2000; 97: 5357–62.

    Article  CAS  PubMed  Google Scholar 

  91. Gohji K, Fidler IJ, Tsan R, Radinsky R, von Eschenbach AC, Tsuruo T, Nakajima M. Human recombinant interferons-beta and -gamma decrease gelatinase production and invasion by human KG-2 renal carcinoma cells. Int J Cancer 1994; 58: 380–4.

    Article  CAS  PubMed  Google Scholar 

  92. Goidl E, ed. Aging and the immune response: cellular and humoral aspects. New York: Marcel Dekker, 1987.

    Google Scholar 

  93. Gorunova L, Hoglund M, Andren-Sandberg A, et al. Cytogenetic analysis of pancreatic carcinomas: intratumor heterogeneity and nonrandom pattern of chromosome aberrations. Genes Chromosomes Cancer 1998; 23: 81–99.

    Article  CAS  PubMed  Google Scholar 

  94. Gottesman MM, Pastan I. Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu Rev Biochem 1993; 62: 385–427.

    Article  CAS  PubMed  Google Scholar 

  95. Griffin CA, Hruban RH, Morsberger LA, et al. Consistent chromosome abnormalities in adenocarcinoma of the pancreas. Cancer Res 1995; 55: 2394–9.

    CAS  PubMed  Google Scholar 

  96. Guo P, Hu B, Gu W, et al. Platelet-derived growth factor-β enhances glioma angiogenesis by stimulating vascular endothelial growth factor expression in tumor endothelia and by promoting pericyte recruitment. Am J Pathol 2003; 162: 1083–93.

    CAS  PubMed  Google Scholar 

  97. Gutman M, Singh RK, Xie K, Bucana CD, Fidler IJ. Regulation of IL-8 expression in human melanoma cells by the organ environment. Cancer Res 1995; 55: 2470–5.

    CAS  PubMed  Google Scholar 

  98. Gutman, M, Singh RK, Yoon S, Xie K, Bucana CD, Fidler IJ. Leukocyte-induced angiogenesis and subcutaneous growth of B16 melanoma. Cancer Biother 1994; 9: 163–70.

    CAS  PubMed  Google Scholar 

  99. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000; 100: 57–70.

    Article  CAS  PubMed  Google Scholar 

  100. Harris AL. Hypoxia – a key regulatory factor in tumour growth. Nat Rev Cancer 2002; 2: 38–47.

    Article  CAS  PubMed  Google Scholar 

  101. Hart IR, Fidler IJ. Role of organ selectivity in the determination of metastatic patterns of B16 melanoma. Cancer Res 1980; 40: 2281–7.

    CAS  PubMed  Google Scholar 

  102. Hedley D, Pintilie M, Woo J, et al. Carbonic anhydrase IX expression, hypoxia, and prognosis in patients with uterine cervical carcinomas. Clin Cancer Res 2003; 9: 5666–74.

    CAS  PubMed  Google Scholar 

  103. Heldin CH, Ostman A, Ronnstrand L. Signal transduction via platelet-derived growth factor receptors. Biochim Biophys Acta 1998; 1378: F79–F113.

    CAS  PubMed  Google Scholar 

  104. Heldin CH, Westermark B. Mechanism of action and in vivo role of platelet-derived growth factor. Physiol Rev 1999; 79: 1283–316.

    CAS  PubMed  Google Scholar 

  105. Herbst RS, Yano S, Kuniyasu H, et al. Differential expression of E-cadherin and type IV collagenase genes predicts outcome in patients with stage I non-small cell lung carcinoma. Clin Cancer Res 2000; 6: 790–7.

    CAS  PubMed  Google Scholar 

  106. Herlyn M. Human melanoma: development and progression. Cancer Metastasis Rev 1990; 9: 101–29.

    Article  CAS  PubMed  Google Scholar 

  107. Herlyn M, Clark WH, Rodeck U, Mancianti ML, Jambrosic J, Koprowski H. Biology of tumor progression in human melano-cytes. Lab Investigation 1987; 56: 461–74.

    CAS  Google Scholar 

  108. Heuchel R, Berg A, Tallqauist M, et al. Platelet-derived growth factor β receptor regulates interstitial fluid homeostasis through phosphatidylinositol-3′ kinase signaling. Proc Natl Acad Sci USA 1999; 86: 11410–5.

    Article  Google Scholar 

  109. Hewitt RE, Powe DG, Carter GI, Turner DR. Desmoplasia and its relevance to colorectal tumour invasion. Int J Cancer 1993; 53: 62–9.

    Article  CAS  PubMed  Google Scholar 

  110. Hicklin DJ, Ellis LM. Role of the vascular endothelial growth factor pathway in tumor-growth and angiogenesis. J Clin Oncol 2005; 23: 1011–27.

    Article  CAS  PubMed  Google Scholar 

  111. Hofmockel G, Riess S, Bassukas ID, Dammrich J. Epidermal growth factor family and renal cell carcinoma: expression and prognostic impact. Eur Urol 1997; 4: 478–84.

    Google Scholar 

  112. Huang S, Van Arsdall M, Tedjarati S, et al. Contributions of stromal metalloproteinase-9 to angiogenesis and growth of human ovarian carcinoma in mice. J Natl Cancer Inst 2002; 94: 1134–42.

    CAS  PubMed  Google Scholar 

  113. Hurwitz H, Fehrenbacher L, Novotny W, et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 2004; 350: 2335–42.

    Article  CAS  PubMed  Google Scholar 

  114. Hwang RF, Yokoi K, Bucana CD, et al. Inhibition of platelet-derived growth factor receptor phosphorylation by STI571 (Gleevec) reduces growth and metastasis of human pancreatic carcinoma in an orthotopic nude mouse model. Clin Cancer Res 2003; 9: 6534–44.

    CAS  PubMed  Google Scholar 

  115. Iizuka N, Oka M, Yamada-Okabe H, et al. Oligonucleotide microarray for prediction of early intrahepatic recurrence of hepatocellular carcinoma after curative resection. Lancet 2003; 361: 923–9.

    Article  CAS  PubMed  Google Scholar 

  116. Ikeda N, Adachi M, Taki T, et al. Prognostic significance of angiogenesis in human pancreatic cancer. Br J Cancer 1999; 79: 1553–63.

    Article  CAS  PubMed  Google Scholar 

  117. Ito M, Yoshida K, Kyo E, et al. Expression of several growth factors and their receptor genes in human colon carcinomas. Virchows Arch B Cell Pathol Incl Mol Pathol 1990; 59: 173–8.

    Article  CAS  PubMed  Google Scholar 

  118. Jain R. Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science 2005; 307: 58–62.

    Article  CAS  PubMed  Google Scholar 

  119. Joseph E, Brobeil A, Glass F, et al. Results of complete lymph node dissection in 83 melanoma patients with positive sentinel nodes. Ann Surg Oncol 1998; 5: 119–25.

    Article  CAS  PubMed  Google Scholar 

  120. Kadowaki T, Shiozaki H, Inoue M, et al. E-cadherin and α-catenin expression in human esophageal cancer. Cancer Res 1994; 54: 291–6.

    CAS  PubMed  Google Scholar 

  121. Kerbel RS. Antiangiogenic therapy: a universal chemosensitiza-tion strategy for cancer? Science 2006; 312: 1171–5.

    Article  CAS  PubMed  Google Scholar 

  122. Kerbel RS. Inhibition of tumor angiogenesis as a strategy to circumvent acquired resistance to anticancer therapeutic agents. BioEssays 1991; 13: 31–6.

    Article  CAS  PubMed  Google Scholar 

  123. Kerbel RS, Folkman J. Clinical translation of angiogenesis inhibitors. Nat Rev Cancer 2002; 2: 727–39.

    Article  CAS  PubMed  Google Scholar 

  124. Killion JJ, Radinsky R, Fidler IJ. Orthotopic models are necessary to predict therapy of transplantable tumors in mice. Cancer Metastasis Rev 1999; 17: 279–84.

    Article  CAS  Google Scholar 

  125. Kim SJ, Uehara H, Karashima T, Shepherd DL, Killion JJ, Fidler IJ. Blockade of epidermal growth factor receptor signaling in tumor cells and tumor-associated endothelial cells for therapy of androgen-independent human prostate cancer growing in the bone of nude mice. Clin Cancer Res 2003; 9: 1200–10.

    CAS  PubMed  Google Scholar 

  126. Kim SJ, Uehara H, Yazici S, et al. Targeting platelet-derived growth factor receptor on endothelial cells of multidrug resistant prostate cancer. J Natl Cancer Inst 2006; 98: 783–93.

    Article  CAS  PubMed  Google Scholar 

  127. Kim SJ, Uehara H, Yazici S, et al. Modulation of bone microenvironment with zoledronate enhances the therapeutic effects of STI571 and paclitaxel against experimental bone metastasis of human prostate cancer. Cancer Res 2005; 65: 3707–15.

    Article  CAS  PubMed  Google Scholar 

  128. Kim SJ, Uehara H, Yazici S, et al. Simultaneous blockade of platelet-derived growth factor-receptor and epidermal growth factorreceptor signaling and systemic administration of Paclitaxel as therapy for human prostate cancer metastasis in bone of nude mice. Cancer Res 2004; 64: 4201–8.

    Article  CAS  PubMed  Google Scholar 

  129. Kitadai Y, Ellis LM, Takahashi Y, et al. Multiparametric in situ mRNA hybridization analysis to detect metastasis-related genes in surgical specimens of human colon carcinoma. Clin Cancer Res 1995; 1: 1095–102.

    CAS  PubMed  Google Scholar 

  130. Kitadai Y, Ellis LM, Tucker SL, et al. Multiparametric in situ mRNA hybridization analysis to predict disease recurrence in patients with colon carcinoma. Am J Pathol 1996; 149: 1541–51.

    CAS  PubMed  Google Scholar 

  131. Kitadai Y, Sasaki T, Kuwai T, et al. Expression of activated platelet-derived growth factor receptor in stromal cells of human colon carcinomas is associated with metastatic potential. Int J Cancer 2006; 119: 2567–74.

    Article  CAS  PubMed  Google Scholar 

  132. Kitadai Y, Sasaki T, Kuwai T, et al. Targeting the expression of platelet-derived growth factor receptor by reactive stroma inhibits growth and metastasis of human colon carcinoma. Am J Pathol 2006; 169: 2054–65.

    Article  CAS  PubMed  Google Scholar 

  133. Kreisle RA, Stebler BA, Ershler WB. Effect of host age on tumor-associated angiogenesis in mice. J Natl Cancer Inst 1990; 82: 44–7.

    Article  CAS  PubMed  Google Scholar 

  134. Kripke ML. Speculation on the role of ultraviolet radiation in the development of malignant melanoma. J Natl Cancer Inst 1979; 63: 541–5.

    CAS  PubMed  Google Scholar 

  135. Kripke ML. Immunologic mechanisms in UV radiation carcino-genesis. Adv Cancer Res 1981; 34: 69–105.

    Article  CAS  PubMed  Google Scholar 

  136. Kripke ML, Fidler IJ. Enhanced experimental metastasis of UV-induced fibrosarcomas in UV-irradiated syngeneic mice. Cancer Res 1980; 40: 625–9.

    CAS  PubMed  Google Scholar 

  137. Kumar R, Dong Z, Fidler IJ. Differential regulation of metal-loelastase activity in murine peritoneal macrophages by GM-CSF and M-CSF. J Immunol 1996; 157: 5104–11.

    CAS  PubMed  Google Scholar 

  138. Kuniyasu H, Ellis LM, Evans DB, et al. Relative expression of E-cadherin and type IV collagenase genes predicts disease outcome in patients with resectable pancreatic carcinoma. Clin Cancer Res 1999; 5: 25–33.

    CAS  PubMed  Google Scholar 

  139. Kuniyasu H, Troncoso P, Johnston D, et al. Relative expression of type IV collagenase, E-cadherin, and vascular endothelial growth factor/vascular permeability factor in prostatectomy specimens distinguishes organ-confined from pathologically advanced prostate cancers. Clin Cancer Res 2000; 6: 2295–308.

    CAS  PubMed  Google Scholar 

  140. Kuwai T, Kitadai Y, Tanaka S, et al. Expression of hypoxia-inducible factor-1alpha is associated with tumor vascularization in human colorectal carcinoma. Int J Cancer 2003; 105: 176–81.

    Article  CAS  PubMed  Google Scholar 

  141. Kuwai T, Nakamura T, Kim SJ, et al. Intratumoral heterogeneity for expression of tyrosine kinase growth factor receptors in human colon cancer surgical specimens and orthotopic tumors. Am J Pathol 2008; 172: 358–66.

    Article  PubMed  Google Scholar 

  142. Langley RR, Fan D, Tsan RZ, et al. Activation of the platelet-derived growth factor receptor enhances survival of murine bone endothelial cells. Cancer Res (Adv in Brief) 2004; 64: 3727–30.

    Article  CAS  Google Scholar 

  143. Langley RR, Ramirez KM, Tsan RZ, Van Arsdall M, Nilsson MB, Fidler IJ. Tissue-specific microvascular endothelial cell lines from H−2k b−tsA58 mice for studies of angiogenesis and metastasis. Cancer Res 2003; 63: 2971–6.

    CAS  PubMed  Google Scholar 

  144. LaRochelle WJ, Jeffers M, McDonald WF, et al. PDGF-D, a new protease-activated growth factor. Nat Cell Biol 2001; 3: 517–21.

    Article  CAS  PubMed  Google Scholar 

  145. Lazard D, Sastre X, Frid MG, Glukhova MA, Thiery JP, Koteliansky VE. Expression of smooth muscle-specific proteins in myoepithelium and stromal myofibroblasts of normal and malignant human breast tissue. Proc Natl Acad Sci USA 1993; 90: 999–1003.

    Article  CAS  PubMed  Google Scholar 

  146. Lee WH, Morton RA, Epstein JI, et al. Cytidine methylation of regulatory sequences near the pi-class glutathione S-transferase gene accompanies human prostatic carcinogenesis. Proc Natl Acad Sci USA 1994; 91: 11733–7.

    Article  CAS  PubMed  Google Scholar 

  147. Lehnert M. Clinical multidrug resistance: a multifactorial problem. Eur J Cancer 1996; 32A: 912–20.

    Article  CAS  PubMed  Google Scholar 

  148. Leung DW, Cachianes G, Kuang WJ, Goeddel DV, Ferrara N. Vascular endothelial growth factor is a secreted angiogenic mito-gen. Science 1989; 246: 1306–9.

    Article  CAS  PubMed  Google Scholar 

  149. Li X, Ponten A, Aase K, et al. PDGF-C is a new protease-acti-vated ligand for the PDGF alpha-receptor. Nat Cell Biol 2000; 2: 302–9.

    Article  CAS  PubMed  Google Scholar 

  150. Lieubeau B, Garrigue L, Barbieux I, Meflah K, Gregoire M. The role of transforming growth factor beta 1 in the fibroblastic reaction associated with rat colorectal tumor development. Cancer Res 1994; 54: 6526–32.

    CAS  PubMed  Google Scholar 

  151. Lindmark G, Sundberg C, Glimelius B, Pahlman L, Rubin K, Gerdin B. Stromal expression of platelet-derived growth factor beta-receptor and platelet-derived growth factor B-chain in col-orectal cancer. Lab Invest 1993; 69: 682–9.

    CAS  PubMed  Google Scholar 

  152. Lingen MW, Polverini PJ, Bouck N. Inhibition of squamous cell carcinoma angiogenesis by direct interaction of retinoic acid with endothelial cells. Lab Invest 1996; 74: 476–83.

    CAS  PubMed  Google Scholar 

  153. Lingen MW, Polverini PJ, Bouck N. Retinoic acid induces cells cultured from oral squamous cell carcinomas to become antian-giogenic. Am J Pathol 1996; 149: 247–58.

    CAS  PubMed  Google Scholar 

  154. Liotta LA. Tumor invasion and metastases – Role of the extracellular matrix: Rhoads memorial award lecture. Cancer Res 1986; 46: 1–7.

    Article  CAS  PubMed  Google Scholar 

  155. Liotta LA, Kohn EC. The microenvironment of the tumor-host invasion field. Nature 2001; 375–9.

    Google Scholar 

  156. Liotta LA, Steeg PS, Stetler-Stevenson WG. Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 1991; 64: 327–36.

    Article  CAS  PubMed  Google Scholar 

  157. Luria SE, Delbruck M. Mutations of bacteria from virus sensitivity to virus resistant. Genetics 1943; 28: 491–511.

    CAS  PubMed  Google Scholar 

  158. Lynch TJ, Bell DW, Sordella R, et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med 2004; 350: 2129–39.

    Article  CAS  PubMed  Google Scholar 

  159. Man S, Bocci G, Francia G, Green S, et al. Anti-tumor and anti-angiogenic effects in mice of low-dose (metronomic) cyclophos-phamide administered continuously through the drinking water. Cancer Res 2002; 62: 2731–5.

    CAS  PubMed  Google Scholar 

  160. Mantovani A, Bottazzi B, Colotta F, Sozzani S, Ruco L. The origin and function of tumor-associated macrophages. Immunol Today 1992; 13: 265–70.

    Article  CAS  PubMed  Google Scholar 

  161. Mareel M, Vleminck K, Vermeulen S, et al. Homotypic cell-cell adhesion molecules and tumor invasion. In: Graumann W, Drukker J, eds. Progress in histo- and cytochemistry: Histochemistry of receptors, vol 26. Sutttgart: Fischer Verlag, 1992; 95–106.

    Google Scholar 

  162. Martin-Orozco E, Ferragut JA, Garcia-Penarrubia P, Ferrer-Montiel A. Acquisition of multidrug resistance by L1210 leukemia cells decreases their tumorigenicity and enhances their susceptibility to the host immune response. Cancer Immunol Immunother 2005; 54: 328–36.

    Article  CAS  PubMed  Google Scholar 

  163. Mattern J, Bak M, Volm M. Intrinsic and acquired multidrug resistance in human lung carcinomas grown in nude mice. Anticancer Res 1990; 10: 177–80.

    CAS  PubMed  Google Scholar 

  164. Menininger IJ, Zetter BR. Mast cells and angiogenesis. Semin Cancer Biol 1992; 3: 73–9.

    Google Scholar 

  165. Micke P, Ostman A. Tumour-stroma interaction: cancer-associated fibroblasts as novel targets in anti-cancer therapy? Lung Cancer 2004; 45(Suppl 2): S163–75.

    Article  PubMed  Google Scholar 

  166. Mickisch GH, Noordzij MA, vd Gaast A, et al. Dexverapamil to modulate vinblastine resistance in metastatic renal cell carcinoma. J Cancer Res Clin Oncol 1995; 121(Suppl 3): R11–6.

    Article  CAS  PubMed  Google Scholar 

  167. Mickisch GH, Pai LH, Gottesman MM, Pastan I. Monoclonal antibody MRK16 reverses the multidrug resistance of multidrug-resistant transgenic mice. Cancer Res 1992; 52: 4427–32.

    CAS  PubMed  Google Scholar 

  168. Mickisch GH, Rahman A, Pastan I, Gottesman MM. Increased effectiveness of liposome-encapsulated doxorubicin in multi-drug-resistant-transgenic mice compared with free doxorubicin. J Natl Cancer Inst 1992; 84: 804–5.

    Article  CAS  PubMed  Google Scholar 

  169. Miguez M, Davel L, deLustig ES. Lymphocyte-induced angio-genesis: correlation with the metastatic incidence of two murine mammary adenocarcinomas. Inv Metastasis 1986; 6: 313–20.

    CAS  Google Scholar 

  170. Moch H, Sauter G, Buchholz N, et al. Epidermal growth factor receptor expression is associated with rapid tumor cell proliferation and renal cell carcinoma. Hum Pathol 1997; 11: 1255–9.

    Article  Google Scholar 

  171. Morikawa K, Walker SM, Jessup JM, Fidler IJ. In vivo selection of highly metastatic cells from surgical specimens of different primary human colon carcinoma implanted into nude mice. Cancer Res 1988; 48: 1943–8.

    CAS  PubMed  Google Scholar 

  172. Morikawa K, Walker SM, Nakajima M, Pathak S, Jessup JM, Fidler IJ. The influence of organ environment on the growth, selection, and metastasis of human colon cancer cells in nude mice. Cancer Res 1988; 48: 6863–71.

    CAS  PubMed  Google Scholar 

  173. Moroni M, Veronese S, Benvenuti S, et al. Gene copy number for epidermal growth factor receptor (EGFR) and clinical response to anti-EGFR treatment in colorectal cancer: a cohort study. Lancet Oncol 2005; 6: 279–86.

    Article  CAS  PubMed  Google Scholar 

  174. Morrow CS, Cowan KH. Glutathione S-transferase and drug resistance. Cancer Cells 1990; 2: 15–22.

    CAS  PubMed  Google Scholar 

  175. Morton DL, Wen D-R, Wong JH, Cochran AJ. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992; 127: 392–9.

    CAS  PubMed  Google Scholar 

  176. Motzer RJ, Lyn P, Fischer P, et al. Phase I/II trial of dexverapamil plus vinblastine for patients with advanced renal cell carcinoma. J Clin Oncol 1995; 13: 1958–65.

    CAS  PubMed  Google Scholar 

  177. Nakajima M, Irimura T, Nicolson GL. Heparanases and tumor metastasis. J Cell Biochem 1988; 36: 157–64.

    Article  CAS  PubMed  Google Scholar 

  178. Nakajima M, Morikawa K, Fabra A, Bucana CD, Fidler IJ. Influence of organ environment on extracellular matrix degrada-tive activity and metastasis of human colon carcinoma cells. J Natl Cancer Inst 1990; 82: 1890–8.

    Article  CAS  PubMed  Google Scholar 

  179. Nakamura T, Fidler IJ, Coombes KR. Gene expression profile of metastatic human pancreatic cancer cells depends on the organ microenvironment. Cancer Res 2007; 67: 139–48.

    Article  CAS  PubMed  Google Scholar 

  180. Nakamura T, Kuwai T, Kitadai Y, et al. Zonal heterogeneity for gene expression in human pancreatic carcinoma. Cancer Res 2007; 67: 7597–604.

    Article  CAS  PubMed  Google Scholar 

  181. Nanus DM, Schmitz-Dräger BJ, Motzer RJ, et al. Expression of basic fibroblast growth factor in primary human renal tumors: correlation with poor survival. J Natl Cancer Inst 1994; 85: 1598–9.

    Google Scholar 

  182. Nels V, Denzer K, Drenchahn D. Pericyte involvement in capillary sprouting during angiogenesis in situ. Cell Tissue Res 1992; 270: 469–74.

    Article  Google Scholar 

  183. Nesbit M, Herlyn M. Adhesion receptors in human melanoma progression. Inv Metastasis 1994–1995; 14: 131–8.

    Google Scholar 

  184. Nguyen M, Watanabe H, Budson AE, Richie JP, Hayes DF, Folkman J. Elevated levels of an angiogenic peptide, basic fibro-blast growth factor, in the urine of patients with a wide spectrum of cancers. J Natl Cancer Inst 1994; 86: 356–61.

    Article  CAS  PubMed  Google Scholar 

  185. Nicolson GL. Metastatic tumor cell attachment and invasion assay utilizing vascular endothelial cell monolayer. J Histochem Cytochem 1982; 30: 214–20.

    CAS  PubMed  Google Scholar 

  186. Nicolson GL. Tumor cell instability, diversification, and progression to the metastatic phenotype: from oncogene to oncofetal expression. Cancer Res 1987; 47: 1473–87.

    CAS  PubMed  Google Scholar 

  187. Nicolson GL, Dulski KM. Organ specificity of metastatic tumor colonization is related to organ-selective growth properties of malignant cells. Int J Cancer 1986; 38: 289–94.

    Article  CAS  PubMed  Google Scholar 

  188. Nigro JM, Baker SJ, Preisinger AC, et al. Mutations in the p53 gene occur in diverse human tumour types. Nature 1989; 342: 705–8.

    Article  CAS  PubMed  Google Scholar 

  189. Nor JE, Polverni PJ. Role of endothelial cell survival and death signals in angiogenesis. Angiogenesis 1999; 3: 101–16.

    Article  CAS  PubMed  Google Scholar 

  190. Nowell PC. The clonal evolution of tumor cell populations. Science 1976; 194: 23–8.

    Article  CAS  PubMed  Google Scholar 

  191. Ohmori H, Fujii K, Sasahira T, et al. Determinants for prediction of malignant potential by metalloproteinase: E-cadherin ratio in prostate core needle biopsy. Pathobiology 2006; 73: 98–104.

    Article  CAS  PubMed  Google Scholar 

  192. Ostman A. PDGF receptors-mediators of autocrine tumor growth and regulators of tumor vasculature and stroma. Cytokine Growth Factor Rev 2004; 15: 275–86.

    Article  PubMed  CAS  Google Scholar 

  193. Paget S. The distribution of secondary growths in cancer of the breast. Lancet 1889; 1: 571–3.

    Article  Google Scholar 

  194. Pasqualini R, Arap W, McDonald DM. Probing the structural and molecular diversity of tumor vasculature. Trends Mol Med 2002; 8: 563–71.

    Article  CAS  PubMed  Google Scholar 

  195. Patel PH, Chaganti RS, Motzer RJ. Targeted therapy for meta-static renal cell carcinoma. Br J Cancer 2006; 94: 614–9.

    CAS  PubMed  Google Scholar 

  196. Pauli BU, Schwartz DE, Thonar EJM, Kuttner KE. Tumor invasion and host extracellular matrix. Cancer Metastasis Rev 1983; 2: 129–53.

    Article  CAS  PubMed  Google Scholar 

  197. Petrylak DP. Chemotherapy for advanced hormone refractory prostate cancer. Urology 1999; 54: 30–5.

    Article  CAS  PubMed  Google Scholar 

  198. Petrylak DP, MacArthur RB, O'Connor J, et al. Phase I trial of Docetaxel with estramustine in androgen-independent prostate cancer. J Clin Oncol 1999; 17: 958–67.

    CAS  PubMed  Google Scholar 

  199. Pietras K. Increasing tumor uptake of anticancer drugs with ima-tinib. Semin Oncol 2004; 31: 18–23.

    Article  CAS  PubMed  Google Scholar 

  200. Pietras K, Hanahan D. A multi-targeted, metronomic, and maximum-tolerated dose “chemo-switch” regimen is antiangiogenic, producing objective responses and survival benefit in a mouse model of cancer. J Clin Oncol 2005; 23: 939–52.

    Article  CAS  PubMed  Google Scholar 

  201. Pietras K, Ostman A, Sjoquist M, et al. Inhibition of platelet-derived growth factor receptors reduces interstitial hypertension and increases transcapillary transport in tumors. Cancer Res 2001; 61: 2929–34.

    CAS  PubMed  Google Scholar 

  202. Pietras K, Rubin K, Sjoblom T, et al. Inhibition of PDGF receptor signaling in tumor stroma enhances antitumor effect of chemotherapy. Cancer Res 2002; 62: 5476–84.

    CAS  PubMed  Google Scholar 

  203. Pietras K, Stumm M, Hubert M, et al. STI571 enhances the therapeutic index of epothilone B by a tumor selective increase of drug uptake. Clin Cancer Res 2003; 9: 3779–87.

    CAS  PubMed  Google Scholar 

  204. Polverini PJ. How the extracellular matrix and macrophages contribute to angiogenesis-dependent diseases. Eur J Cancer 1996; 32A: 2430–7.

    Article  CAS  PubMed  Google Scholar 

  205. Polverini PJ, Cotran PS, Gimbrone MA Jr. Activated macrophages induce vascular proliferation. Nature 1977; 269: 804–6.

    Article  CAS  PubMed  Google Scholar 

  206. Polverini JJ, Leibovich SJ. Induction of neovascularization in vivo and endothelial cell proliferation in vitro by tumor-associated macrophages. Lab Invest 1984; 51: 635–42.

    CAS  PubMed  Google Scholar 

  207. Pomeroy SL, Tamayo P, Gaasenbeek M, et al. Prediction of central nervous system embryonal tumour outcome based on gene expression. Nature 2002; 415: 436–42.

    Article  CAS  PubMed  Google Scholar 

  208. Poste G. Pathogenesis of metastatic disease: implications for current therapy and for the development of new therapeutic strategies. Cancer Treat Rep 1986; 70: 183–99.

    CAS  PubMed  Google Scholar 

  209. Poste G, Fidler IJ. The pathogenesis of cancer metastasis. Nature 1979; 283: 139–46.

    Article  Google Scholar 

  210. Poste G, Doll J, Fidler IJ. Interactions among clonal subpopulations affect stability of the metastatic phenotype in polyclonal populations of B16 melanoma cells. Proc Natl Acad Sci USA 1981; 78: 6226–30.

    Article  CAS  PubMed  Google Scholar 

  211. Ramadori G, Veit T, Schwogler S, et al. Expression of the gene of the alpha-smooth muscle-actin isoform in rat liver and in rat fat-storing (ITO) cells. Virchows Arch B Cell Pathol Incl Mol Pathol 1990; 59: 349–57.

    Article  CAS  PubMed  Google Scholar 

  212. Ripple M, Mulcahy RT, Wilding G. Characteristics of the glutathione/glutathione-S-transferase detoxification system in melphalan resistant human prostate cancer cells. J Urol 1993; 150: 209–14.

    CAS  PubMed  Google Scholar 

  213. Risau W, Drexler H, Mironov V, Smits A, Siegbahn A, Funa K, Heldin CH. Platelet-derived growth factor is angiogenic in vivo. Growth Factors 1992; 7: 261–6.

    Article  CAS  PubMed  Google Scholar 

  214. Rittmann-Grauer LS, Yong MA, Sanders V, Mackensen DG. Reversal of Vinca alkaloid resistance by anti-P-glycoprotein monoclonal antibody HYB-241 in a human tumor xenograft. Cancer Res 1992; 52: 1810–6.

    CAS  PubMed  Google Scholar 

  215. Rènnov-Jessen L, Petersen OW, Bissell MJ. Cellular changes involved in conversion of normal to malignant breast: importance of the stromal reaction. Physiol Rev 1996; 76: 69–125.

    Google Scholar 

  216. Rosenwald A, Wright G, Chan WC, et al. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med. 2002; 346: 1937–47.

    Article  PubMed  Google Scholar 

  217. Ruiter DJ, Bhan AK, Harrist TJ, Sober AJ, Mihm MC Jr. Major histocompatibility antigens and mononuclear inflammatory infiltrate in benign nevomelanocytic proli and malignant melanoma. J Immunol 1982; 129: 2808–15.

    CAS  PubMed  Google Scholar 

  218. Ruoslahti E. Fibronectin and its α5β 1 integrin receptor in malignancy. Inv Metastasis 1994–1995; 14: 87–94.

    CAS  Google Scholar 

  219. Schackert G, Fidler IJ. Site-specific metastasis of mouse melanomas and a fibrosarcoma in the brain or the meninges of syngeneic animals. Cancer Res 1988; 48: 3478–84.

    CAS  PubMed  Google Scholar 

  220. Schackert G, Price JE, Zhang RD, Bucana CD, Itoh K, Fidler IJ. Regional growth of different human melanoma as meta-stases in the brain of nude mice. Am J Pathol 1990; 136: 95–102.

    CAS  PubMed  Google Scholar 

  221. Sharifi N, Gulley JL, Dahut WL. Androgen deprivation therapy for prostate cancer. J Am Med Assoc 2005; 294: 238–44.

    Article  CAS  Google Scholar 

  222. Shimizu S, Yamada N, Sawada T, et al. In vivo and in vitro interactions between human colon carcinoma cells and hepatic stellate cells. Jpn J Cancer Res 2000; 91: 1285–95.

    CAS  PubMed  Google Scholar 

  223. Sidky YA, Auerbach R. Lymphocyte-induced angiogenesis in tumor-bearing mice. Science 1976; 192: 1237–8.

    Article  CAS  PubMed  Google Scholar 

  224. Sieweke MH, Bissell MJ. The tumor-promoting effect of wounding: a possible role for TGF-beta-induced stromal alterations. Crit Rev Oncol 1994; 5: 297–311.

    CAS  Google Scholar 

  225. Sigalotti L, Fratta E, Coral S, et al. Intratumor heterogeneity of cancer/testis antigens expression in human cutaneous melanoma is methylation-regulated and functionally reverted by 5-aza-2′-deoxycytidine. Cancer Res 2004; 64: 9167–71.

    Article  CAS  PubMed  Google Scholar 

  226. Singh RK, Bucana CD, Gutman M, Fan D, Wilson MR, Fidler IJ. Organ-site dependent expression of bFGF in human renal cell carcinoma cells. Am J Pathol 1994; 145: 365–74.

    CAS  PubMed  Google Scholar 

  227. Singh RK, Gutman M, Bucana CD, Sanchez R, Llansa N, Fidler IJ. Interferons alpha and beta downregulate the expression of basic fibroblast growth factor in human carcinomas. Proc Natl Acad Sci USA 1995; 92: 4562–6.

    Article  CAS  PubMed  Google Scholar 

  228. Singh RK, Gutman M, Radinsky R, Bucana CD, Fidler IJ. Expression of interleukin 8 correlates with the metastatic potential of human melanoma cells in nude mice. Cancer Res 1994; 54: 3242–7.

    CAS  PubMed  Google Scholar 

  229. Slaton JW, Perrotte P, Inoue K, Dinney CPN, Fidler IJ. Interferon-alpha-mediated downregulation of angiogenesis-related genes and therapy of bladder cancer are dependent on optimization of dose and schedule. Clin Cancer Res 1995; 2726–34.

    Google Scholar 

  230. Sloane BF, Honn KV. Cysteine proteinase and metastasis. Cancer Metastasis Rev 1984; 3: 249–65.

    Article  CAS  PubMed  Google Scholar 

  231. Smith DC, Esper P, Strawderman M, Redman B, Poenta KJ. Phase II trial of oral estramustine, oral etoposide, and intravenous paclitaxel in hormone-refractory prostate cancer. J Clin Oncol 1999; 17: 1664–71.

    CAS  PubMed  Google Scholar 

  232. Solorzano CC, Baker CH, Tsan R, et al. Optimization for the blockade of epidermal growth factor receptor signaling for therapy of human pancreatic carcinoma. Clin Cancer Res 2001; 7: 2563–72.

    CAS  PubMed  Google Scholar 

  233. Stetler-Stevenson WG. Invasion and metastasis. In: DeVita WT Jr, Hellman S, Rosenberg SA, eds. Cancer: principles and practice of oncology, 7th edt. Philadelphia, PA: Lippincott, Williams & Wilkins, 2005; 113–126.

    Google Scholar 

  234. Strohmeyer D, Rossing C, Bauerfeind A, et al. Vascular endothelial growth factor and its correlation with angiogenesis and p53 expression in prostate cancer. Prostate 2000; 45: 216–24.

    Article  CAS  PubMed  Google Scholar 

  235. Sugarbaker E V. Cancer metastasis: a product of tumor-host interactions. Curr Probl Cancer 1979; 3: 1–59.

    Article  CAS  PubMed  Google Scholar 

  236. Sugarbaker EV, Cohen AM, Ketcham AS. Do metastases metas-tasize? Ann Surg 1971; 174: 161–70.

    Article  CAS  PubMed  Google Scholar 

  237. Sullivan GF, Amenta PS, Villanueva JD, Alvarez CJ, Yang JM, Hait WN. The expression of drug resistance gene products during the progression of human prostate cancer. Clin Cancer Res 1998; 4: 1393–403.

    CAS  PubMed  Google Scholar 

  238. Sundberg C, Ljungstrom M, Lindmark G, Gerdin B, Rubin K. Microvascular pericytes express platelet-derived growth factor-beta receptors in human healing wounds and colorectal adenocar-cinoma. Am J Pathol 1993; 143: 1377–88.

    CAS  PubMed  Google Scholar 

  239. Sunderkötter C, Goebeler M, Schulze-Osthoff K, Bhardwaj R, Sorg C. Macrophage-derived angiogenesis factors. Pharmacol Ther 1991; 51: 195–216.

    Article  PubMed  Google Scholar 

  240. Sunderkötter C, Steinbrink K, Goebeler M, Bhardwaj R, Sorg C. Macrophages and angiogenesis. J Leukoc Biol 1994; 55: 410–22.

    PubMed  Google Scholar 

  241. Takahashi Y, Bucana CD, Liu W, et al. Platelet derived endothelial cell growth factor in human colon cancer angiogenesis: role of infiltrating cells. J Natl Cancer Inst 1996; 88: 1091–2.

    Article  Google Scholar 

  242. Takahashi Y, Kitadai Y, Bucana CD, Cleary KR, Ellis LM. Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer. Cancer Res 1995; 55: 3964–8.

    CAS  PubMed  Google Scholar 

  243. Talmadge JE, Fidler IJ. Enhanced metastatic potential of tumor cells harvested from spontaneous metastases of heterogeneous murine tumors. J Natl Cancer Inst 1982; 69: 975–80.

    CAS  PubMed  Google Scholar 

  244. Talmadge JE, Wolman SR, Fidler IJ. Evidence for the clonal origin of spontaneous metastasis. Science 1982; 217: 361–3.

    Article  CAS  PubMed  Google Scholar 

  245. Tarin D, Price JE, Kettlewell MGW, Souter RG, Vass ACR, Crossley B. Mechanisms of human tumor metastasis studied in patients with peritoneovenous shunts. Cancer Res 1984; 44: 3584–92.

    CAS  PubMed  Google Scholar 

  246. Terranova VP, Hujanen ES, Martin GR. Basement membrane and the invasive activity of metastatic tumor cells. J Natl Cancer Inst 1986; 77: 311–6.

    CAS  PubMed  Google Scholar 

  247. Thatcher N, Chang A, Parikh P, et al. Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer). Lancet 2005; 366: 1527–37.

    Article  CAS  PubMed  Google Scholar 

  248. Theyer G, Schirmbock M, Thalhammer T, et al. Role of the MDR-1-encoded multiple drug resistance phenotype in prostate cancer cell lines. J Urol 1993; 150: 1544–7.

    CAS  PubMed  Google Scholar 

  249. Tsuruo T. Mechanisms of multidrug resistance and implications for therapy. Jpn J Cancer Res 1988; 79: 285–96.

    CAS  PubMed  Google Scholar 

  250. Tuxhorn JA, Ayala GE, Rowley DR. Reactive stroma in prostate cancer progression. J Urol 2001; 166: 2472–83.

    Article  CAS  PubMed  Google Scholar 

  251. Uehara H, Kim SJ, Karashima T, et al. Effects of blocking platelet-derived growth factor-receptor signaling in a mouse model of prostate cancer bone metastasis. J Natl Cancer Inst 2003; 95: 458–70.

    Article  CAS  PubMed  Google Scholar 

  252. Uemura A, Ogawa M, Hirashima M, et al. Recombinant angio-poietin-1 restores higher-order architecture of growing blood vessels in mice in the absence of mural cells. J Clin Invest 2002; 110: 1619–28.

    CAS  PubMed  Google Scholar 

  253. Uhlman DL, Nguyen P, Manicel JC, et al. Epidermal growth factor receptor and transforming growth factor α expression in papillary and non papillary renal cell carcinoma: correlation with metastatic behavior and prognosis. Clin Cancer Res 1995; 1: 913–20.

    CAS  PubMed  Google Scholar 

  254. van Brussel JP, Busstra MB, Lang MS, Catsburg T, Schroder FH, Mickisch GH. A phase II study of temozolomide in hormone-refractory prostate cancer. Cancer Chemother Pharmacol 2000; 45: 509–12.

    Article  PubMed  Google Scholar 

  255. van Brussel JP, Mickisch GHJ. Multidrug resistance in prostate cancer. Onkologie 2003; 26: 175–81.

    Article  PubMed  Google Scholar 

  256. van Brussel JP, van Steenbrugge GJ, Romijn JC, Schroder FH, Mickisch GH. Chemosensitivity of prostate cancer cell lines and expression of multidrug resistance-related proteins. Eur J Cancer 1999; 35: 664–71.

    Article  PubMed  Google Scholar 

  257. van Brussel JP, van Steenbrugge GJ, Van Krimpen C, et al. Expression of multidrug resistance related proteins and prolifera-tive activity is increased in advanced clinical prostate cancer. J Urol 2001; 165: 130–5.

    Article  PubMed  Google Scholar 

  258. van de Vijver MJ, He YD, van't Veer LJ, et al. A gene expression signature as a predictor of survival in breast cancer. N Engl J Med 2002; 347: 1999–2009.

    Article  PubMed  Google Scholar 

  259. van ‘t Veer LJ, Dai H, van de Vijver MJ, et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature 2002; 415: 530–6.

    Article  PubMed  Google Scholar 

  260. Vaupel P, Mayer A, Hockel M. Tumor hypoxia and malignant progression. Meth Enzymol 2004; 381: 335–54.

    Article  CAS  PubMed  Google Scholar 

  261. Vermeulen SJ, Bruyneel EA, Bracke ME, et al. Transition from the noninvasive to the invasive phenotype and loss of α-catenin in human colon cancer cells. Cancer Res 1995; 55: 4722–8.

    CAS  PubMed  Google Scholar 

  262. Volm M, Koomagi R, Mattern J. Prognostic value of vascular endothelial growth factor and its receptor Flt-1 in squamous cell lung cancer. Int J Cancer 1997; 74: 64–8.

    Article  CAS  PubMed  Google Scholar 

  263. Wang Y, Jatkoe T, Zhang Y, et al. Gene expression profiles and molecular markers to predict recurrence of Dukes' B colon cancer. J Clin Oncol 2004; 22: 1564–71.

    Article  CAS  PubMed  Google Scholar 

  264. Weiss L. Metastasis of cancer: a conceptual history from antiquity to the 1990s. Cancer Metastasis Rev 2000; 19: 193–400.

    Article  Google Scholar 

  265. Weiss L. Principles of metastasis. Orlando, FL: Academic Press, 1985.

    Google Scholar 

  266. Wilhelm SM, Carter C, Tang L, et al. BAY 43–9006 exhibits broad spectrum oral antitumor activity and targets the RAF/ MEK/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis. Cancer Res 2004; 64: 7099–109.

    Article  CAS  PubMed  Google Scholar 

  267. Wilmanns C, Fan D, O'Brian CA, Radinsky R, Bucana CD, Tsan R, Fidler IJ. Modulation of doxorubicin sensitivity and level of P-glycoprotein expression in human colon carcinoma cells by ectopic and orthotopic environments in nude mice. Int J Oncol 1993; 3: 413–22.

    CAS  Google Scholar 

  268. Xu L, Xie K, Mukaida N, Matsushima K, Fidler IJ. Hypoxia-induced elevation in interleukin-8 expression by human ovarian carcinoma cells. Cancer Res 1999; 59: 5822–9.

    CAS  PubMed  Google Scholar 

  269. Yokoi K, Kim SJ, Thaker P, et al. Induction of apoptosis in tumor-associated endothelial cells and therapy of orthotopic human pancreatic carcinoma in nude mice. Neoplasia 2005; 7: 696–704.

    Article  PubMed  Google Scholar 

  270. Yokoi K, Sasaki T, Bucana CD, et al. Simultaneous inhibition of EGFR, VEGFR, and platelet-derived growth factor receptor signaling combined with gemcitabine produces therapy of human pancreatic carcinoma and prolongs survival in an orthotopic nude mouse model. Cancer Res 2005; 65: 10371–80.

    Article  CAS  PubMed  Google Scholar 

  271. Yoshida K, Tosaka A, Takeuchi S, Kobayashi N. Epidermal growth factor receptor content in human renal cell carcinomas. Cancer 1994; 73: 1913–8.

    Article  CAS  PubMed  Google Scholar 

  272. Yuan F, Chen Y, Dellian M, Safabakhsh N, Ferrara N, Jain RK. Time-dependent vascular regression and permeability changes in established human tumor xenografts induced by an anti-vascular endothelial growth factor/vascular permeability factor antibody. Proc Natl Acad Sci USA 1996; 93: 14765–70.

    Article  CAS  PubMed  Google Scholar 

  273. Zhai BJ, Wu F, Shao ZY, Hu K, Wang ZB. Establishment of human multidrug-resistant hepatocellular carcinoma cell line (HepG2/Adm) and biological characteristics evaluation. Ai Zheng 2004; 23: 391–5.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Cancer Biology, M. D. Anderson Cancer Center, The University of Texas, Houston, TX, USA

    Sun-Jin Kim, Cheryl Hunt Baker, Yasuhiko Kitadai, Toru Nakamura, Toshio Kuwai, Takamitsu Sasaki, Robert Langley & Isaiah J. Fidler

Authors
  1. Sun-Jin Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Cheryl Hunt Baker
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yasuhiko Kitadai
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Toru Nakamura
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Toshio Kuwai
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Takamitsu Sasaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Robert Langley
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Isaiah J. Fidler
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Hematology-Oncology Associates of Southeast Missouri Hospital, Southeast Medical Plaza, Cape Girardeau, MO, USA

    Robert K. Oldham

  2. Hoag Cancer Center, Newport Beach, CA, USA

    Robert O. Dillman

  3. University of California, Irvine, CA, USA

    Robert O. Dillman

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Springer Science+Business Media B.V.

About this chapter

Cite this chapter

Kim, SJ. et al. (2009). The pathogenesis of cancer metastasis: relevance to therapy. In: Oldham, R.K., Dillman, R.O. (eds) Principles of Cancer Biotherapy. Springer, Dordrecht. https://doi.org/10.1007/978-90-481-2289-9_2

Download citation

Publish with us

Policies and ethics

Search

Navigation